Company Filing History:
Years Active: 2014
Title: Tania Crombet Ramos: Innovator in Vaccine Development
Introduction
Tania Crombet Ramos is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. Her innovative work has the potential to improve therapeutic outcomes for cancer patients.
Latest Patents
Tania holds a patent for a method of making a homogeneous vaccine composition comprising a conjugate of Epidermic Growth Factor (EGF) and a protein known as P64k. This patent, which is crucial for the treatment of tumors, describes a vaccine composition that includes a chemical conjugate of human recombining EGF and P64k. The conjugation reaction produces this chemical conjugate in a controlled and reproducible manner. The preferred conjugate surprisingly enhances immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation allows for multiple effective dose presentations, enabling an increase in the immunization dose per patient without raising the frequency or number of immunization sites.
Career Highlights
Tania is affiliated with the Centro de Inmunología Molecular (CIM), where she continues her research and development efforts. Her work at CIM has positioned her as a key figure in the advancement of immunological therapies.
Collaborations
Tania collaborates with talented coworkers, including Gryssell Rodriguez Martinez and Lisel Vina Rodriguez. Their combined expertise contributes to the innovative research environment at CIM.
Conclusion
Tania Crombet Ramos is a trailblazer in the field of vaccine development, with her patented methods offering promising solutions for cancer treatment. Her contributions to immunology are paving the way for future advancements in therapeutic vaccines.